573 related articles for article (PubMed ID: 10441109)
1. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
Lim PO; Yee KM
Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
[No Abstract] [Full Text] [Related]
2. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
Elam MB; Cushman W; Applegate WB; Heimberg M
Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
[No Abstract] [Full Text] [Related]
3. [Primary and secondary prevention of coronary disease by statins].
Ferrières J
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of the West of Scotland Coronary Prevention Study.
DeFilippis AP; Bansal S; Blumenthal RS
N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527
[No Abstract] [Full Text] [Related]
5. [WOSCOPS [West of Scotland Coronary Prevention Study]].
Furutani N; Tada N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():387-92. PubMed ID: 11347100
[No Abstract] [Full Text] [Related]
6. Long-term follow-up of the West of Scotland Coronary Prevention Study.
Tsubokura M; Kami M
N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526
[No Abstract] [Full Text] [Related]
7. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
8. Updated guidelines support even lower cholesterol levels for at-risk patients.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
[No Abstract] [Full Text] [Related]
9. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
März W
MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
[No Abstract] [Full Text] [Related]
10. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of the West of Scotland Coronary Prevention Study.
Ford I; Murray H; Packard CJ; Shepherd J; Macfarlane PW; Cobbe SM;
N Engl J Med; 2007 Oct; 357(15):1477-86. PubMed ID: 17928595
[TBL] [Abstract][Full Text] [Related]
12. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
Gotto AM; Kuller LH
Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
[No Abstract] [Full Text] [Related]
13. [Hyperlipidemia: decreasing lipid values and effects of statins].
Mathes P
Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
[No Abstract] [Full Text] [Related]
14. Long-term follow-up of the West of Scotland Coronary Prevention Study.
McEvoy JW; Margey R; Blake GJ
N Engl J Med; 2008 Jan; 358(2):193; author reply 194-5. PubMed ID: 18184967
[No Abstract] [Full Text] [Related]
15. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
Windler E
Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
[No Abstract] [Full Text] [Related]
16. Cholesterol and coronary heart disease: new data from the WOSCOP Study.
Poli A
Pharmacol Res; 1997 Mar; 35(3):171-2. PubMed ID: 9229403
[No Abstract] [Full Text] [Related]
17. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
18. ["No infarct without elevated LDL cholesterol"!].
Greten H
MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
[No Abstract] [Full Text] [Related]
19. [Statin treatment in type 2 diabetes. Is it a must today?].
Faust M
MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
[No Abstract] [Full Text] [Related]
20. Primary prevention of coronary artery disease.
Domanski MJ
N Engl J Med; 2007 Oct; 357(15):1543-5. PubMed ID: 17928603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
